These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1317592)

  • 1. Neuroendocrine evidence for decreased function of alpha 2-adrenergic receptor after electroconvulsive therapy.
    Balldin J; Berggren U; Lindstedt G; Modigh K
    Psychiatry Res; 1992 Mar; 41(3):257-65. PubMed ID: 1317592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.
    Coote M; Wilkins A; Werstiuk ES; Steiner M
    J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone and somatomedin serum levels in patients with major depressive illness undergoing electroconvulsive therapy.
    Apéria B; Thorén M; Undén F; Wetterberg L
    Acta Psychiatr Scand; 1986 Jun; 73(6):681-7. PubMed ID: 3751671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noradrenergic responses to clonidine in acute and remitted depressed male patients.
    Trestman RL; Lawrence TL; Coccaro EF; Harvey P; Bernstein D; Lawrence EK; Condello V; Mahon T; Yang RK; Knott P
    Psychiatry Res; 1992 Sep; 43(3):199-213. PubMed ID: 1332095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects.
    Charney DS; Heninger GR; Sternberg DE; Hafstad KM; Giddings S; Landis DH
    Arch Gen Psychiatry; 1982 Mar; 39(3):290-4. PubMed ID: 6279050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of electroconvulsive therapy on plasma insulin and glucose in depression.
    Williams K; Smith J; Glue P; Nutt D
    Br J Psychiatry; 1992 Jul; 161():94-8. PubMed ID: 1638337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy.
    Balldin J; Granérus AK; Lindstedt G; Modigh K; Wålinder J
    Psychopharmacology (Berl); 1982; 76(4):371-6. PubMed ID: 6812112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-2 adrenergic receptor sensitivity and the mechanism of action of antidepressant therapy. The effect of long-term amitriptyline treatment.
    Charney DS; Heninger GR; Sternberg DE
    Br J Psychiatry; 1983 Mar; 142():265-75. PubMed ID: 6305451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of desipramine upon central adrenergic function in depressed patients.
    Glass IB; Checkley SA; Shur E; Dawling S
    Br J Psychiatry; 1982 Oct; 141():372-6. PubMed ID: 6293637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone response to clonidine in untreated depressed patients.
    Schittecatte M; Charles G; Machowski R; Wilmotte J
    Psychiatry Res; 1989 Aug; 29(2):199-206. PubMed ID: 2798598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neuroendocrine study of the mechanism of action of ECT.
    Slade AP; Checkley SA
    Br J Psychiatry; 1980 Sep; 137():217-21. PubMed ID: 7437656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal responses to clonidine and urinary MHPG in delusional and nondelusional melancholic patients: a placebo-controlled study.
    Lykouras L; Markianos M; Hatzimanolis J; Malliaras D; Stefanis C
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):77-81. PubMed ID: 1657199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic receptors in depression. Effects of electroconvulsive therapy.
    Cooper SJ; Kelly JG; King DJ
    Br J Psychiatry; 1985 Jul; 147():23-9. PubMed ID: 2998528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls.
    Siever LJ; Uhde TW; Silberman EK; Jimerson DC; Aloi JA; Post RM; Murphy DL
    Psychiatry Res; 1982 Apr; 6(2):171-83. PubMed ID: 6283576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone and physiological responses to clonidine in depression.
    Katona CL; Healy D; Paykel ES; Theodorou AE; Lawrence KM; Whitehouse A; White B; Horton RW
    Psychol Med; 1993 Feb; 23(1):57-63. PubMed ID: 8475215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-2-adrenoceptor sensitivity in early alcohol withdrawal.
    Balldin J; Berggren U; Engel J; Lindstedt G; Sundkler A; Wålinder J
    Biol Psychiatry; 1992 Apr; 31(7):712-9. PubMed ID: 1318083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of growth hormone response after clonidine and insulin hypoglycemia in affective illness.
    Amsterdam JD; Maislin G
    Biol Psychiatry; 1990 Aug; 28(4):308-14. PubMed ID: 2204433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment.
    Charney DS; Heninger GR; Sternberg DE; Redmond DE; Leckman JF; Maas JW; Roth RH
    Arch Gen Psychiatry; 1981 Dec; 38(12):1334-40. PubMed ID: 6274268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine.
    Siever LJ; Uhde TW
    Biol Psychiatry; 1984 Feb; 19(2):131-56. PubMed ID: 6324896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone responses to intravenous clonidine challenge correlate with behavioral irritability in psychiatric patients and healthy volunteers.
    Coccaro EF; Lawrence T; Trestman R; Gabriel S; Klar HM; Siever LJ
    Psychiatry Res; 1991 Nov; 39(2):129-39. PubMed ID: 1665918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.